“… 39 , 40 The decision of whether to prescribe EAI in EDs may be confounded by the difficulties prescribers face in determining whether patients have indeed had anaphylaxis. 41 , 42 In such cases, it might be preferable for ED prescribers to defer the decision until a formal allergy review; however, data from retrospective studies indicate that only a minority of patients are referred to allergists on ED discharge. 36 , 43 This is also of concern when considering patients treated in the ED for nonanaphylaxis reactions who arguably meet guidelines for EAI prescription.…”